Emerade 150, 300, 500
The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received reports of Emerade pens failing to activate. This means that in some cases, the needle is not released, and the injection of adrenaline is not delivered. This alert is an update to the previous drug alert issued on 03 October 2019. People in the UK who have been supplied with an Emerade are advised of the following:
Emerade 150, 300, 500.